The U.S. Food and Drug Administration (FDA) is expected to decide on two new peanut allergy therapies in the next 6 months. These emerging medications are expected shift how patients with this condition are treated. The American College of Allergy, Asthma, & Immunology estimates approximately 2.2% of children and adolescents have a peanut allergy. Allergic [...]